Business & Regulation

Pfizer and Allergan are to combine to form the world’s biggest pharma behemoth – for tax?

Considering Ebola's impact, how can we incentivize development in other important health areas?

Is the reverse merger between Pfizer and Allergan the most recent chapter in a troubling trend?

How do your customers, your competitors, the press or even the public perceive your organization?

Sitting Down With... Raman Singh, President, Mundipharma Asia Pacific, Latin America, Middle East and Africa.

Advanced digital technologies are sweeping through the world and changing the way we live our lives and do business.

We sit down with Siu Ping Lam, Director of Licensing Division at the UK's Medicines and MHRA.

Starting a bioanalytical research company after years working for Big Pharma has been daunting…

“The best-laid schemes o’mice an’ men” often go awry – and that can apply to your outsourcing plans.

What if we could treat bacterial infection earlier and without adding to drug resistance?